vs

Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and Zeta Global Holdings Corp. (ZETA). Click either name above to swap in a different company.

Zeta Global Holdings Corp. is the larger business by last-quarter revenue ($394.6M vs $207.8M, roughly 1.9× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 1.7%, a 55.7% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $60.9M).

IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.

Zeta Global Holdings Corp. is an American marketing technology company which was founded in 2007. Zeta offers companies a suite of multichannel marketing tools focused on creating, maintaining, and monetizing customer relationships. The company went public on the New York Stock Exchange on June 10, 2021, at a US$1.7 billion valuation.

IDYA vs ZETA — Head-to-Head

Bigger by revenue
ZETA
ZETA
1.9× larger
ZETA
$394.6M
$207.8M
IDYA
Higher net margin
IDYA
IDYA
55.7% more per $
IDYA
57.4%
1.7%
ZETA
More free cash flow
IDYA
IDYA
$81.3M more FCF
IDYA
$142.2M
$60.9M
ZETA

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
IDYA
IDYA
ZETA
ZETA
Revenue
$207.8M
$394.6M
Net Profit
$119.2M
$6.5M
Gross Margin
59.5%
Operating Margin
52.2%
4.5%
Net Margin
57.4%
1.7%
Revenue YoY
25.4%
Net Profit YoY
330.1%
-57.1%
EPS (diluted)
$1.33
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IDYA
IDYA
ZETA
ZETA
Q4 25
$394.6M
Q3 25
$207.8M
$337.2M
Q2 25
$308.4M
Q1 25
$264.4M
Q4 24
$314.7M
Q3 24
$0
$268.3M
Q2 24
$0
$227.8M
Q1 24
$0
$194.9M
Net Profit
IDYA
IDYA
ZETA
ZETA
Q4 25
$6.5M
Q3 25
$119.2M
$-3.6M
Q2 25
$-12.8M
Q1 25
$-21.6M
Q4 24
$15.2M
Q3 24
$-51.8M
$-17.4M
Q2 24
$-52.8M
$-28.1M
Q1 24
$-39.6M
$-39.6M
Gross Margin
IDYA
IDYA
ZETA
ZETA
Q4 25
59.5%
Q3 25
60.5%
Q2 25
62.1%
Q1 25
60.9%
Q4 24
60.0%
Q3 24
60.6%
Q2 24
60.0%
Q1 24
60.6%
Operating Margin
IDYA
IDYA
ZETA
ZETA
Q4 25
4.5%
Q3 25
52.2%
2.6%
Q2 25
-1.7%
Q1 25
-6.1%
Q4 24
2.2%
Q3 24
-4.6%
Q2 24
-11.7%
Q1 24
-18.4%
Net Margin
IDYA
IDYA
ZETA
ZETA
Q4 25
1.7%
Q3 25
57.4%
-1.1%
Q2 25
-4.2%
Q1 25
-8.2%
Q4 24
4.8%
Q3 24
-6.5%
Q2 24
-12.3%
Q1 24
-20.3%
EPS (diluted)
IDYA
IDYA
ZETA
ZETA
Q4 25
$0.04
Q3 25
$1.33
$-0.02
Q2 25
$-0.06
Q1 25
$-0.10
Q4 24
$0.10
Q3 24
$-0.60
$-0.09
Q2 24
$-0.68
$-0.16
Q1 24
$-0.53
$-0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IDYA
IDYA
ZETA
ZETA
Cash + ST InvestmentsLiquidity on hand
$786.9M
$319.8M
Total DebtLower is stronger
$197.1M
Stockholders' EquityBook value
$1.1B
$804.6M
Total Assets
$1.2B
$1.5B
Debt / EquityLower = less leverage
0.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IDYA
IDYA
ZETA
ZETA
Q4 25
$319.8M
Q3 25
$786.9M
$385.2M
Q2 25
$365.3M
Q1 25
$364.4M
Q4 24
$366.2M
Q3 24
$920.0M
$418.5M
Q2 24
$701.7M
$154.7M
Q1 24
$698.8M
$141.6M
Total Debt
IDYA
IDYA
ZETA
ZETA
Q4 25
$197.1M
Q3 25
$196.9M
Q2 25
$196.7M
Q1 25
$196.5M
Q4 24
$196.3M
Q3 24
$196.1M
Q2 24
$184.4M
Q1 24
$184.2M
Stockholders' Equity
IDYA
IDYA
ZETA
ZETA
Q4 25
$804.6M
Q3 25
$1.1B
$689.2M
Q2 25
$673.3M
Q1 25
$676.6M
Q4 24
$676.8M
Q3 24
$1.2B
$474.9M
Q2 24
$931.7M
$217.0M
Q1 24
$935.3M
$191.6M
Total Assets
IDYA
IDYA
ZETA
ZETA
Q4 25
$1.5B
Q3 25
$1.2B
$1.2B
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$1.1B
Q3 24
$1.2B
$869.1M
Q2 24
$973.7M
$583.9M
Q1 24
$961.5M
$550.3M
Debt / Equity
IDYA
IDYA
ZETA
ZETA
Q4 25
0.24×
Q3 25
0.29×
Q2 25
0.29×
Q1 25
0.29×
Q4 24
0.29×
Q3 24
0.41×
Q2 24
0.85×
Q1 24
0.96×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IDYA
IDYA
ZETA
ZETA
Operating Cash FlowLast quarter
$142.2M
$64.1M
Free Cash FlowOCF − Capex
$142.2M
$60.9M
FCF MarginFCF / Revenue
68.4%
15.4%
Capex IntensityCapex / Revenue
0.0%
0.8%
Cash ConversionOCF / Net Profit
1.19×
9.81×
TTM Free Cash FlowTrailing 4 quarters
$13.5M
$185.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IDYA
IDYA
ZETA
ZETA
Q4 25
$64.1M
Q3 25
$142.2M
$57.9M
Q2 25
$42.0M
Q1 25
$34.8M
Q4 24
$43.7M
Q3 24
$-49.2M
$34.4M
Q2 24
$-32.9M
$31.1M
Q1 24
$-43.8M
$24.7M
Free Cash Flow
IDYA
IDYA
ZETA
ZETA
Q4 25
$60.9M
Q3 25
$142.2M
$52.4M
Q2 25
$39.7M
Q1 25
$32.1M
Q4 24
$35.4M
Q3 24
$-49.7M
$29.5M
Q2 24
$-33.9M
$24.4M
Q1 24
$-45.1M
$18.9M
FCF Margin
IDYA
IDYA
ZETA
ZETA
Q4 25
15.4%
Q3 25
68.4%
15.6%
Q2 25
12.9%
Q1 25
12.1%
Q4 24
11.3%
Q3 24
11.0%
Q2 24
10.7%
Q1 24
9.7%
Capex Intensity
IDYA
IDYA
ZETA
ZETA
Q4 25
0.8%
Q3 25
0.0%
1.6%
Q2 25
0.8%
Q1 25
1.0%
Q4 24
2.6%
Q3 24
1.8%
Q2 24
3.0%
Q1 24
3.0%
Cash Conversion
IDYA
IDYA
ZETA
ZETA
Q4 25
9.81×
Q3 25
1.19×
Q2 25
Q1 25
Q4 24
2.87×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons